Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=18501505&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Multitargeted therapy of cancer by green tea polyphenols Khan N; Mukhtar HCancer Lett 2008[Oct]; 269 (2): 269-80Tea ranks second only to water as a major component of fluid intake worldwide and has been considered a health-promoting beverage since ancient times. For the past two decades, we and others have been investigating the potential cancer preventive and therapeutic effects of green tea and its polyphenolic mixture termed GTP. It has become clear that much of these effects of GTP are mediated by its most abundant catechin, epigallocatechin gallate (EGCG). Large amount of encouraging data from in vitro and animal models has emerged making clear that green tea is a nature's gift molecule endowed with anticancer effects. Epidemiological and geographical observations suggest that these laboratory data may be applicable to human population. Clinical trials of GTP, especially in prostate cancer patients have yielded encouraging results. This article briefly reviews properties of GTP, especially EGCG with reference to multitargeted therapy of cancer.|Anticarcinogenic Agents/*pharmacology[MESH]|Apoptosis/drug effects[MESH]|Biological Availability[MESH]|Catechin/*analogs & derivatives/pharmacokinetics/pharmacology/therapeutic use[MESH]|Cell Cycle/drug effects[MESH]|ErbB Receptors/antagonists & inhibitors[MESH]|Flavonoids/pharmacokinetics/*pharmacology/therapeutic use[MESH]|Humans[MESH]|Insulin-Like Growth Factor I/antagonists & inhibitors[MESH]|MAP Kinase Signaling System/drug effects[MESH]|Matrix Metalloproteinase Inhibitors[MESH]|NF-kappa B/antagonists & inhibitors[MESH]|Neoplasms/*drug therapy[MESH]|Phenols/pharmacokinetics/*pharmacology/therapeutic use[MESH]|Polyphenols[MESH]|Signal Transduction/drug effects[MESH]|Tea/*chemistry[MESH]|Transcription Factor AP-1/antagonists & inhibitors[MESH]|Urokinase-Type Plasminogen Activator/antagonists & inhibitors[MESH] |
